PUMA BIOTECHNOLOGY, INC. Adjustments to Additional Paid in Capital, Warrant Issued
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Adjustments to Additional Paid in Capital, Warrant Issued of $18.22 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-02.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2015-03-02
- PUMA BIOTECHNOLOGY, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-12-31 was $11.97M.
- PUMA BIOTECHNOLOGY, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-09-30 was $6.46M.
- PUMA BIOTECHNOLOGY, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-06-30 was -$65.31K.
- PUMA BIOTECHNOLOGY, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-03-31 was -$149.28K.
- PUMA BIOTECHNOLOGY, INC. adjustments to additional paid in capital, warrant issued for fiscal 2012 was $18.22M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 1 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|---|
| 2012-12-31 | $11.97M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $18.44M derived: sum of 2 quarters · filed 2015-03-02 | $18.37M derived: sum of 3 quarters · filed 2015-03-02 | $18.22M 10-K · filed 2015-03-02 | ||
| 2012-09-30 | $6.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $6.40M derived: sum of 2 quarters · filed 2012-11-14 | $6.25M 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | -$65.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$214.59K 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | -$149.28K 10-Q · filed 2012-05-15 | |||||
| 2011-12-31 | $7.59M 10-Q · filed 2014-11-10 | $7.59M 10-K · filed 2012-03-29 | ||||
| 2011-10-31 | $1.80M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |